GALNT16 Antibody, Biotin conjugated
-
中文名稱：GALNT16兔多克隆抗體, Biotin偶聯
-
貨號：CSB-PA850796LD01HU
-
規格：￥880
-
其他：
產品詳情
-
產品名稱：Rabbit anti-Homo sapiens (Human) GALNT16 Polyclonal antibody
-
Uniprot No.：
-
基因名：GALNT16
-
別名：GALNT16 antibody; GALNTL1 antibody; KIAA1130Polypeptide N-acetylgalactosaminyltransferase 16 antibody; EC 2.4.1.41 antibody; Polypeptide GalNAc transferase 16 antibody; GalNAc-T16 antibody; Polypeptide GalNAc transferase-like protein 1 antibody; GalNAc-T-like protein 1 antibody; pp-GaNTase-like protein 1 antibody; Polypeptide N-acetylgalactosaminyltransferase-like protein 1 antibody; Protein-UDP acetylgalactosaminyltransferase-like protein 1 antibody; UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-like protein 1 antibody
-
宿主：Rabbit
-
反應種屬：Human
-
免疫原：Recombinant Human Polypeptide N-acetylgalactosaminyltransferase 16 protein (301-558AA)
-
免疫原種屬：Homo sapiens (Human)
-
標記方式：Biotin
-
克隆類型：Polyclonal
-
抗體亞型：IgG
-
純化方式：>95%, Protein G purified
-
濃度：It differs from different batches. Please contact us to confirm it.
-
保存緩沖液：Preservative: 0.03% Proclin 300
Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 -
產品提供形式：Liquid
-
應用范圍：ELISA
-
Protocols：
-
儲存條件：Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
貨期：Basically, we can dispatch the products out in 1-3 working days after receiving your orders. Delivery time maybe differs from different purchasing way or location, please kindly consult your local distributors for specific delivery time.
-
用途：For Research Use Only. Not for use in diagnostic or therapeutic procedures.
產品評價
相關產品
靶點詳情
-
功能：Catalyzes the initial reaction in O-linked oligosaccharide biosynthesis, the transfer of an N-acetyl-D-galactosamine residue to a serine or threonine residue on the protein receptor.
-
亞細胞定位：Golgi apparatus membrane; Single-pass type II membrane protein.
-
蛋白家族：Glycosyltransferase 2 family, GalNAc-T subfamily
-
數據庫鏈接：
Most popular with customers
-
-
Phospho-YAP1 (S127) Recombinant Monoclonal Antibody
Applications: ELISA, WB, IHC
Species Reactivity: Human
-
-
-
-
-
-
